Antiretinal antibodies in central serous chorioretinopathy: prevalence and clinical implications

Publisher： John Wiley & Sons Inc

E-ISSN： 1755-3768|96|1|56-62

ISSN： 1755-375X

Source： ACTA OPHTHALMOLOGICA, Vol.96, Iss.1, 2018-02, pp. : 56-62

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Central serous chorioretinopathy misdiagnosed as posterior uveitis

By  

ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Central serous chorioretinopathy complicating inflammation suppressive treatment

By  

ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Changes in choroidal thickness after photodynamic therapy in patients with central serous chorioretinopathy

By  

ACTA OPHTHALMOLOGICA, Vol. 92, Iss. 1, 2014-02 ,pp. : e79-e79

John Wiley & Sons Inc

Access to resources Recommend Favorite

Spironolactone in the treatment of nonresolving central serous chorioretinopathy: a comparative analysis

By  

ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Analysis of macular sensitivity using multifocal electroretinogram and microperimetry in central serous chorioretinopathy patients after half‐dose photodynamic therapy

By  

ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite